Kantonsspital St.Gallen

Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial

Christoph Neuwirth

abstract A multicenter, non-randomized, open label trial, to assess long term safety and efficacy of Arimoclomol in subjects with Amyotrophic Lateral Sclerosis (ALS)who have completed the ORARIALS-01 trial.
type of project clinical studies
status aborted
start of project 2019
end of project 2021
responsible person Neuwirth, Christoph